Previous 10 | Next 10 |
Nova LifeStyle (NVFY) +231%.Siebert Financial (SIEB) +63% on Q4 results.Vir Biotechnology (VIR) +60% as its and GSK's COVID-19 antibody drug reduces hospitalization, death by 85%.OrganiGram Holdings (OGI) +40% on cannabis product deal with British American Tobacco.China HGS Rea...
Gainers: [[SNSE]] +17.5%. [[ABCL]] +8.3%. [[AGLE]] +7.6%. [[OLED]] +5.9%. [[EOLS]] +5.4%.Losers: [[CRWD]] -7.0%. [[ARDX]] -6.9%. [[NK]] -6.6%. [[CATB]] -3.2%. [[ISEE]] -3.1%. For further details see: SNSE, AGLE, CRWD and ISEE among after-hours movers
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, plans to present a corporate overview and provide information about our lead program QLS-215, in preclinical development for the treatment ...
Gainers: [[SIOX]] +12.1%. [[OPTN]] +7.2%. [[BDSI]] +5.7%. [[SSP]] +4.9%. [[SPPI]] +4.9%.Losers: [[PCTI]] -6.5%. [[SVC]] -5.4%. [[GNFT]] -4.2%. [[NIU]] -3.4% [[CATB]] -2%. For further details see: NIU, SPPI, BDSI and SVC among after-hours movers
Today, we take a look at a small biopharma concern called Catabasis Pharmaceuticals for the first time. This Busted IPO recently made a well-received acquisition after a huge trial disappointment in October. Can the company continue to recover from its catastrophic failure in deve...
Gainers: Comstock Mining (LODE) +125%.Viela Bio (VIE) +53%.Dynavax Technologies (DVAX) +47%.Avino Silver & Gold Mines (ASM) +46%.Ferroglobe (GSM) +43%.Alithya (ALYA) +39%.Tuscan Holdings (THCB) +35%.Sundial Growers (SNDL) +32%.Inovio Pharmaceuticals (INO) +31%.Bio...
Gainers: Viela Bio VIE +53%, Dynavax Technologies DVAX +36%, Applied Therapeutics (APLT) +29%, BioCryst Pharmaceuticals BCRX +28%, Vaxart (VXRT) +26%.Losers: Matinas BioPharma MTNB -33%, Concert Pharmaceuticals CNCE -31%,...
Concert Pharmaceuticals (CNCE) -47% after CTP-692 study in schizophrenia fails to meet primary or secondary endpoint.Universal Security Instruments (UUU) -18%.Quotient (QTNT) -15% despite FQ3 beat.Yield10 Bioscience (YTEN) -14% after pricing share offering.17 Edu...
Gainers: [[ADMS]] +13.2%. [[CTMX]] +5.6%. [[MSTR]] +4.9%. [[FARM]] +4.8%. [[NERV]] +4%.Losers: [[CATB]] -10.6%. [[PTVE]] -8%. [[MRVI]] -3.9%. [[ZI]] -3.8%. [[ICON]] -3.5%. For further details see: MSTR, ZI, ADMS and CATB among after-hours movers
Gainers: Siebert Financial (SIEB) +248%.Catabasis Pharmaceuticals (CATB) +155%.Koss (KOSS) +89%.GameStop (GME) +75%.AMC Entertainment (AMC) +64%.Novavax (NVAX) +60%.Vaxart (VXRT) +47%.LM Funding America (LMFA) +39%.Express (EXPR) +32%.Naked Brand (NAKD) +28%.Losers: New Co...
News, Short Squeeze, Breakout and More Instantly...
Catabasis Pharmaceuticals Inc. Company Name:
CATB Stock Symbol:
NASDAQ Market:
Catabasis Pharmaceuticals Inc. Website:
-- Astria Reflects Company’s Patient-Focused Mission -- -- Promising Lead Program STAR-0215 is in Preclinical Development to Prevent Attacks in Hereditary Angioedema -- -- Company to Begin Trading Under New Ticker Symbol ATXS on September 9 -- Cataba...
Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update. “We are focused on advancing the development of our lead program, QLS-215, as a differe...